GHK‑Copper for Hair Regrowth
*A naturally occurring copper‑binding tripeptide that may restore youthful hair growth.*
GHK‑Copper (glycyl‑histidyl‑lysine‑copper) is a three‑amino‑acid peptide that tightly binds copper and circulates naturally in the body. Dr. Jason Schuster explains that its decline with age correlates with hair thinning, and supplementing it may help reverse hair loss while supporting broader tissue health.
A Small Peptide With Big Potential
GHK is a tri‑peptide composed of glycine, histidine, and lysine. On its own it has modest activity, but its high affinity for copper transforms it into GHK‑Copper, a compound shown in studies to influence skin, bone, liver, and especially hair biology.
- Naturally occurring in plasma (≈200 ng/mL in 25‑year‑olds, ≈80 ng/mL in 60‑year‑olds).
- Present in many topical skin‑care products.
- Has been investigated since the 1970s.
How GHK‑Copper Influences Hair Follicles
According to Dr. Schuster, GHK‑Copper modulates gene expression, turning down oncogenic pathways and up‑regulating factors like basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF). These molecules stimulate blood‑vessel formation and cellular migration—processes essential for delivering nutrients to hair follicles and supporting new follicle growth.
- Reverses expression of ~70 % of genes linked to metastatic colon cancer (study referenced).
- Increases VEGF and bFGF, promoting micro‑vascular health in scalp tissue.
- Acts as a migration stimulant for macrophages and other white‑blood cells.
Why Users Turn to GHK‑Copper
Dr. Schuster highlights several health‑related outcomes observed in human and animal studies. For hair, the peptide is noted as “one of the primary things people use it for.” Additional benefits include accelerated wound healing, reduced inflammation, enhanced collagen synthesis, and possible anti‑cancer gene modulation.
- Improves hair density and reduces shedding (clinical observations).
- Supports collagen pathways, benefiting skin and connective tissue.
- Reduces oxidative stress and inflammation.
- Shows anti‑cancer gene expression effects without increasing tumor growth in studied models.
Practical Guidance
Dr. Schuster cites dosing recommendations from Dr. Edwin Lee of the Clinical Peptide Society. Topical application (spray or dropper) is typically 5 mg per day, with visible results after about three months. Injectable protocols use 2.5 mg subcutaneously three times weekly. The peptide has a strong safety record; lethal dose data in mice (LD50 ≈8 mg for a 25 g mouse) extrapolates to a very high margin of safety for humans.
- Topical: 5 mg daily (spray or dropper).
- Injection: 2.5 mg subcutaneously, three times per week.
- No serious adverse events reported in clinical studies.
- LD50 in mice ≈8 mg (25 g) → far above therapeutic human doses.
“GHK is a naturally occurring tripeptide that binds copper and has been heavily studied for hair loss.”— Dr. Jason Schuster
Go deeper than the summary
Dr. Schuster's board-certified, accredited peptide therapy courses — the full research, dosing, and video breakdowns.